These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension. Shimada K, Kawamoto A, Matsubayashi K, Chikamori T, Kuzume O, Ozawa T. Clin Ther; 1990; 12(2):118-24. PubMed ID: 1972351 [Abstract] [Full Text] [Related]
6. [Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol]. Lohmöller G, Conca W, Pötzl C. Med Klin (Munich); 1987 Sep 18; 82(19):647-50. PubMed ID: 3683326 [No Abstract] [Full Text] [Related]
9. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol. Saito K, Furuta Y, Sano H, Yokoyama M, Fukuzaki H. Clin Ther; 1994 Sep 18; 16(2):181-90. PubMed ID: 8062314 [Abstract] [Full Text] [Related]
10. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia]. Lohmöller G, Middeke M, Mrowka C, Pötzl C, Renner W, Zoller W. Med Klin (Munich); 1989 Feb 15; 84(2):81-5. PubMed ID: 2651861 [Abstract] [Full Text] [Related]
19. [Comparative study of penbutolol and atenolol in the therapy of essential hypertension]. Fallo F, Pisani G, Mantero F. Clin Ter; 1988 Jun 30; 125(6):425-30. PubMed ID: 2973948 [No Abstract] [Full Text] [Related]